Glucuronyltransferase Engineering Service
Functions of UDP-Glucuronosyltransferase (UGT)
UGT is a microsomal glycosyltransferase. The enzyme catalyzes the glucuronosylation reaction of glucuronic acid with a large number of chemicals. With the cloning of the UGT gene and the successful expression of the gene product, the function and gene structure of UGT have become better understood. UGT is mainly found in the endoplasmic reticulum membrane and nuclear membrane of hepatocytes. It is also present to varying degrees in other organs and tissues such as the kidney, gastrointestinal tract, skin, brain, etc. UGT metabolizes not only foreign chemicals but also endogenous chemicals such as bilirubin, short-chain fatty acids, bile acids, and fat-soluble vitamins. In addition, UGT has an important physiological role in the metabolism of steroids and thyroid hormones. It is also involved in the biosynthesis of sugar esters in the brain and the clearance of aromatic substances.
At CD BioGlyco, our UGT addresses these limitations by leveraging advanced gene engineering techniques to develop customized, highly efficient, and robust enzymes. Our service is designed to unlock the full potential of these biocatalysts, providing a powerful tool for researchers and developers in the pharmaceutical, chemical, and agricultural sectors.
Key Technologies
We employ advanced gene editing to make highly specific changes to the UGT gene. This technology allows us to precisely target and alter specific nucleotides, introducing point mutations, insertions, or deletions to modify the enzyme's amino acid sequence. This targeted approach is ideal for rational design strategies where specific residues are known to be critical for substrate binding or catalytic function.
Driving Innovation in Glycobiology with UGT Engineering
CD BioGlyco has realized knockdown, insertion, suppression, overexpression, and many other purposes of genes. Our team will provide the best quality UGT gene editing services. The services include but are not limited to the following.
Fig.1 Types of UGT gene editing. (CD BioGlyco)
- UGT gene editing service
UGT is common and widely studied in phase II drug metabolism. It is mainly involved in phenol, bilirubin, and steroid metabolism. It plays a central role in the metabolism and detoxification of a wide range of compounds. Members of this enzyme family catalyze the generation of glucuronic acid which is more polar and easier to excrete than the substrate molecule. We use various Techniques for Gene Editing to study the function of UGT genes in detoxification and their correlation with disease. We also exogenously express UGT genes by constructing microbial expression systems and insect cell expression systems. Various substrates are used to characterize their activities, and their applications in drug metabolism studies are explored. The UGT genes are involved in UDP-glucuronyltransferase 1A1 (UGT1A1), UDP-glucuronylglycosyltransferase 1A3 (UGT1A3), UDP-glucuronylglycosyltransferase 1A8 (UGT1A8), etc.
UGT1A1
UGT1A1 is a member of the phase II metabolizing enzyme family and the only enzyme that metabolizes detoxified bilirubin. UGT1A1 all possibilities of genetically related disorders include GS and CN, neurological disorders, hepatic and biliary disorders, metabolic difficulties, gallstones, cardiovascular disease, diabetes mellitus, leukemias, tumorigenesis, etc.
UGT1A3
There are 4 phenotypes of the UGT1A3 allele, UGT1A3-1, UGTIA3-2, UGT1A3-3, and UGT1A3-4. UGT1A3 is inactivated by forming glucuronide conjugates with many drugs and toxicants.
UGT1A8
UGT1A8 is part of the UGT1 locus, which is involved in the metabolism of dietary and environmental carcinogens. It is expressed in the gastrointestinal tract and extrahepatic tissues. The four alleles of UGT1A8 are UGT1A8α1, UGT1A8β1, UGT1A8β2 and UGT1A8β3.
- UGT gene family analysis service
There are still some species in which UGT has not been reported. We provide the UGT gene family analysis service. We analyze the UGT gene family by bioinformatics method and identify members of the UGT gene family. We also study the specific functions of the gene family through physical and chemical characterization, phylogenetic analysis, chromosomal localization, gene structure, conserved motif analysis, etc. Upon request, we also construct UGT gene mutants to validate the function of UGT and to clarify the detoxification function of UGT.
Workflow
Publication Data
Journal: Frontiers in Genetics
IF: 2.8
Published: 2020
Results: Through genome analysis, 10 AccUGT genes were identified, all of which showed upregulated expression under various pesticide treatments, indicating their involvement in pesticide detoxification. Functional experiments revealed that overexpression of AccUGT2B20-like in Escherichia coli enhanced resistance to oxidative stressors. Conversely, RNAi-mediated silencing of AccUGT2B20-like in honeybees reduced the expression of antioxidant-related genes, decreased activities of superoxide dismutase (SOD), catalase (CAT), and peroxidase (POD), and increased malondialdehyde (MDA) levels, exacerbating oxidative stress. These findings demonstrate that AccUGTs, particularly AccUGT2B20-like, contribute to pesticide resistance in Apis cerana cerana by mitigating oxidative stress, providing insights into the molecular basis of bee resilience to pesticides and supporting ecological balance preservation.
Fig.2 Phylogenetic analysis and tissue-specific expression patterns of Apis cerana cerana UGT genes. (Cui, et al., 2020)
Applications
- The relationship between plants and insects is constantly evolving. The use of UGT gene editing makes it possible to reverse insect resistance.
- UGTs in microorganisms are not well studied. The technologies for UGT gene editing are used to study the function of this type of enzyme in organisms.
- UGT abnormalities are correlated with the development of certain diseases. The technologies for UGT gene editing are used to study the mechanisms of disease development.
Highlights
- Compared to traditional gene modification techniques, our editing is highly efficient and minimizes the experimental period.
- We have a wide range of high-quality insect, yeast, mammalian, and bacterial expression systems to choose from.
- The use of UGT gene editing helps to study the detoxification function and thus provides a new direction for the development of new insecticides and drugs.
Frequently Asked Questions
CD BioGlyco applies proven technologies for gene editing to realize the construction of multi-domain in vitro models. Our experienced researchers provide customized Gene Editing services and advice upon request. In addition to UGT, we also offer GAG Polymerase Engineering Service and Sulfotransferase Engineering Service. For detailed UGT gene editing services, please feel free to contact us.
Associated Services
We synthesize custom glycan libraries for use in screening or as acceptor substrates for your engineered enzyme.
We offer full-service synthesis of complex glycoconjugates for drug discovery and vaccine development.
We provide comprehensive solutions for the synthesis, modification, and analysis of sialic acids.
Reference
- Cui, X.; et al. Molecular mechanism of the UDP-glucuronosyltransferase 2B20-like gene (AccUGT2B20-like) in pesticide resistance of Apis cerana cerana. Frontiers in Genetics. 2020, 11: 592595. (Open Access)
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




